Insights

Innovative IVF Solutions ImVitro focuses on utilizing artificial intelligence to improve the success rate and transparency of IVF treatments, presenting an opportunity to collaborate with fertility clinics and medical institutions seeking to adopt advanced reproductive technologies.

Growing Investment Momentum With recent seed funding of $2.5 million led by notable venture capital firms, ImVitro demonstrates strong investor confidence, indicating potential for expanded technical development and partnerships within the health tech sector.

Market Focus on Fertility Targeting the European fertility market where IVF success rates are relatively low, ImVitro’s solutions are well-positioned to address the high emotional and financial costs faced by patients, making it attractive to fertility clinics and healthcare providers.

Technology Stack Compatibility Using a blend of AI (Keras), ISO standards, and web technologies, ImVitro’s platform offers integration potential with existing medical systems, providing opportunities for healthcare IT vendors to develop complementary tools or integrations.

Early Stage Growth Potential As a pre-seed stage startup with a small team, ImVitro offers opportunities for strategic partnerships, pilot programs, or co-development initiatives with organizations interested in early adoption of innovative reproductive health solutions.

Similar companies to ImVitro

ImVitro Tech Stack

ImVitro uses 8 technology products and services including ISO, Akamai, WordPress, and more. Explore ImVitro's tech stack below.

  • ISO
    Certificates
  • Akamai
    Content Delivery Network
  • WordPress
    Content Management System
  • Funding Choices
    Cookie Compliance
  • Google Fonts API
    Font Scripts
  • Keras
    Machine Learning
  • Google Analytics
    Web Analytics
  • Contact Form 7
    Web Platform Extensions

ImVitro's Email Address Formats

ImVitro uses at least 1 format(s):
ImVitro Email FormatsExamplePercentage
First@im-vitro.comJohn@im-vitro.com
100%

Frequently Asked Questions

Where is ImVitro's headquarters located?

Minus sign iconPlus sign icon
ImVitro's main headquarters is located at 130 Rue Lourmel Paris, Île-de-france 75015 France. The company has employees across 2 continents, including EuropeNorth America.

What is ImVitro's official website and social media links?

Minus sign iconPlus sign icon
ImVitro's official website is im-vitro.com and has social profiles on LinkedIn.

What is ImVitro's NAICS code?

Minus sign iconPlus sign icon
ImVitro's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does ImVitro have currently?

Minus sign iconPlus sign icon
As of June 2026, ImVitro has approximately 11 employees across 2 continents, including EuropeNorth America. Key team members include Us Clinical Partnership Manager: D. D.Lead Computer Vision Engineer: G. C.: T. M.. Explore ImVitro's employee directory with LeadIQ.

What industry does ImVitro belong to?

Minus sign iconPlus sign icon
ImVitro operates in the Medical Equipment Manufacturing industry.

What technology does ImVitro use?

Minus sign iconPlus sign icon
ImVitro's tech stack includes ISOAkamaiWordPressFunding ChoicesGoogle Fonts APIKerasGoogle AnalyticsContact Form 7.

What is ImVitro's email format?

Minus sign iconPlus sign icon
ImVitro's email format typically follows the pattern of First@im-vitro.com. Find more ImVitro email formats with LeadIQ.

How much funding has ImVitro raised to date?

Minus sign iconPlus sign icon
As of June 2026, ImVitro has raised $2.5M in funding. The last funding round occurred on Dec 05, 2022 for $2.5M.

When was ImVitro founded?

Minus sign iconPlus sign icon
ImVitro was founded in 2019.
ImVitro logo

ImVitro

Medical Equipment ManufacturingÎle-de-france, France11-50 Employees

ImVitro is a Paris-based early-stage Deep Tech startup focused on advancing in vitro fertilization through artificial intelligence, aiming to make IVF more transparent, robust, and reproducible for patients and clinics. The company targets individuals facing fertility issues and seeks to reduce the emotional and financial burden of repeated IVF cycles by improving outcomes and consistency. Operating within the medical equipment manufacturing sector, ImVitro positions itself at the intersection of healthcare technology and fertility treatment, with a goal of addressing a key challenge in Europe where IVF success rates are relatively modest. The organization is based in Paris, Île-de-France, and has established itself as a small, growth-oriented enterprise planning to scale its offerings from a modular, patient-centered perspective. A notable recent development is its involvement with a seed-round-backed expansion led by a broad group of early-stage investors as part of its early-stage growth trajectory.

Section iconCompany Overview

Headquarters
130 Rue Lourmel Paris, Île-de-france 75015 France
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2019
Employees
11-50

Section iconFunding & Financials

  • $2.5M

    ImVitro has raised a total of $2.5M of funding over 3 rounds. Their latest funding round was raised on Dec 05, 2022 in the amount of $2.5M.

  • $1M

    ImVitro's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $2.5M

    ImVitro has raised a total of $2.5M of funding over 3 rounds. Their latest funding round was raised on Dec 05, 2022 in the amount of $2.5M.

  • $1M

    ImVitro's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.